|Standard Report||Premium Report|
|Current State of the Industry|
|Market Size (industry trends)|
|Market Forecast (5-year projection)|
|Revenue per State|
|Salary & Compensation Statistics|
|Public Company Information|
|Key Private Companies|
|Instant Download - Available immediately upon purchase|
|Download both PDF and Excel
2023 U.S. Industry Statistics & Market Forecast - Blood & Organ Banks
Market Size & Industry Statistics
The total U.S. industry market size for Blood & Organ Banks:
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
|Statistics||2017 2018 2019 2020 2021 2022|
Order at top of page
|Average Revenue Per Firm|
|Average Employees Per Firm|
|Average Revenue Per Employee|
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year / six-year demand forecast projects both short-term and long-term trends.
|Forecast / Industry Outlook||2023||2024||2025||2026||2027||2028|
|Market Forecast ($ millions)|
|Projected Industry Growth Rate (%)|
Industry InsightsThe Blood & Organ Banks industry is witnessing several key trends that are transforming the healthcare landscape. Firstly, the industry is moving towards more efficient and streamlined processes, aided by advanced technologies such as robotic automation, artificial intelligence, and the internet of things. This trend is aimed at improving the speed and accuracy of diagnoses, facilitating personalized treatments, and enhancing the overall quality of care for patients.
Secondly, there is a growing trend towards personalized medicine, which involves the use of genetic information to tailor treatments to individual patients. This trend is expected to generate substantial demand for blood and organ banks, as genetic information can be used to match organs and blood products with patients, thereby reducing the risk of complications and rejection.
Thirdly, there is an increased focus on patient safety, which is driving stricter regulation and oversight of the industry. This has led to the adoption of new standards for blood and organ banking, as well as a focus on quality control and continuous improvement.
Finally, there is a growing awareness of the need for diversity in organ and blood donors. This trend is expected to drive increased diversity in donor populations, as well as the development of new technologies and processes to expand the availability of organs and blood products. Overall, these trends are likely to have a significant impact on the Blood & Organ Banks industry, driving innovation, growth, and improved patient outcomes.
Product & Services BreakdownResearch products and services in the Blood & Organ Banks industry generating sales. Note that products are broken into categories with different levels of classification.
|Product Description||Number of Companies||Sales ($ millions)||Percent of Total Sales|
Human Blood Services
Human Red Blood Cell (Erythrocytes) Collection, Processing, And Distribution Services
Human Blood Plasma Collection, Processing, And Distribution Services
All Other Human Blood Services
Human Organ, Tissue, And Cell Bank Services
Human - Organ Bank Services
Human - Tissue Bank Services
Human - Reproductive And Stem Cell Bank Services
U.S. Geographic Distribution: Revenue Statistics by StateMarket Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.
Income Statement (Average Financial Metrics)Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.
|Industry Average||Percent of Sales|
Order at top of page
|Cost of Goods Sold|
|Pension, profit sharing plans, stock, annuity|
|Rent paid on business property|
|Domestic production activities deduction|
|Compensation of officers|
|Salaries and wages|
|Employee benefit programs|
|Taxes and Licenses|
|Other Operating Expenses|
|Total Operating Expenses|
|EBIT (Earnings Before Interest and Taxes)|
|Earnings Before Taxes|
Financial Ratio AnalysisFinancial ratio information can be used to benchmark how a Blood & Organ Banks company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.
|Profitability & Valuation Ratios||Industry Average|
|Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Blood & Organ Banks industry is performing.|
Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues.
|Return on Equity (ROE)
Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings).
|Return on Assets (ROA)
Return on Assets (ROA) is net income relative to total assets. The market research on Blood & Organ Banks measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets.
|Liquidity Ratios||Industry Average|
|Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability.|
Measures a firm's ability to pay its debts over the next 12 months.
|Quick Ratio (Acid Test)
Calculates liquid assets relative to liabilities, excluding inventories.
|Efficiency Ratios - Key Performance Indicators||Industry Average|
|Measure how quickly products and services sell, and effectively collections policies are implemented.|
|Receivables Turnover Ratio
If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections.
|Average Collection Period
Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover
A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort.
Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue.
Compensation & Salary Surveys for EmployeesCompensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.
|Title||Percent of Workforce||Bottom Quartile||Average (Median) Salary||Upper Quartile|
Order at top of page
|General and Operations Managers||2%|
|Business and Financial Operations Occupations||7%|
|Business Operations Specialists||6%|
|Healthcare Practitioners and Technical Occupations||30%|
|Healthcare Diagnosing or Treating Practitioners||13%|
|Health Technologists and Technicians||16%|
|Clinical Laboratory Technologists and Technicians||7%|
|Healthcare Support Occupations||24%|
|Other Healthcare Support Occupations||21%|
|Miscellaneous Healthcare Support Occupations||21%|
|Office and Administrative Support Occupations||18%|
|Information and Record Clerks||7%|
Blood & Organ Banks Competitor Landscape & Key Companies [PREMIUM]The most influential companies in the Blood & Organ Banks industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Blood & Organ Banks industry and adjacent sectors:
Companies with the largest market share, focused in this industry
|Market leaders: |
Largest companies that have diversified operations in this and other industries
Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry.
Innovators and Disruptors in adjacent industries that may also affect the Blood & Organ Banks industry.
Government ContractsIn 2022, the federal government spent a total of $228,746,887 on Blood & Organ Banks. It has awarded 263 contracts to 64 companies, with an average value of $3,574,170 per company.
|Most Recent Contracts||Date||Total Award Amount|